Cover Image

Systemic Adverse Events Associated with Locally Administered Corticosteroids

Topical corticosteroids are a mainstay in the treatment of many pediatric disorders. While they have proven beneficial therapeutic effects and are generally considered safe, systemic adverse events may occur. This study presents four cases of children who experienced systemic adverse events after us...

Full description

Saved in:

Bibliographic Details
Main Authors:	Femke De Vleeschhauwer (Author), Kristina Casteels (Author), Ilse Hoffman (Author), Marijke Proesmans (Author), Anne Rochtus (Author)
Format:	Book
Published:	MDPI AG, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
by: Ranferi Ocaña-Guzmán, et al.
Published: (2023)

Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States
by: Jonathan I. Silverberg, et al.
Published: (2024)

Analysis of Corticosteroid-Induced Glaucoma Using the Japanese Adverse Drug Event Reporting Database
by: Ayano Kawabe, et al.
Published: (2023)

Systemic adverse reactions to local anesthetics
by: Tijanić Miloš, et al.
Published: (2019)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
by: Matthew S. Duprey, et al.
Published: (2019)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
by: Xianglin Pan, et al.
Published: (2024)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2022)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022)

Cutaneous and Systemic Adverse Effect of Topical Corticosteroid Misuse on Iraqi Women
by: Teeba H. Sagban, et al.
Published: (2024)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
by: Yujin Choi, et al.
Published: (2024)

The Effect of Incompletely Administered Antenatal Corticosteroids on Neonatal Pulmonary Outcomes in Late Preterm Infants
by: Hyunsu Kim, et al.
Published: (2022)

Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature
by: Evi Jaspers, et al.
Published: (2022)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
by: Pan Ma, et al.
Published: (2022)

Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System
by: Haoning Guo, et al.
Published: (2022)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023)

ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT
by: A. A. Toporov, et al.
Published: (2018)

SYSTEMIC CORTICOSTEROIDS ASSOCIATED WITH INTRATYMPANIC CORTICOSTEROID TREATMENT FOR IDIOPATHIC SUDDEN HEARING LOSS
by: Bogdan Cavaleriu, et al.
Published: (2013)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data
by: Yiming Li, et al.
Published: (2024)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
by: Christine Learned, BA, et al.
Published: (2022)

Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
by: Haoning Guo, et al.
Published: (2022)

Adverse events from topical corticosteroid use in chronic hand eczema - Findings from the Danish Skin CohortCapsule Summary
by: Alexander Egeberg, MD, PhD, DMSc, et al.
Published: (2024)

Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
by: Concetta Rafaniello, et al.
Published: (2021)

Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS)
by: KaiLi Mao, et al.
Published: (2024)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023)

The prevalence of adverse drug event-related admissions at a local hospital in Malaysia
by: Mahmathi Karuppannan, et al.
Published: (2013)

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2024)

Corticosteróides sistêmicos na prática dermatológica. Parte I: Principais efeitos adversos Systemic corticosteroids in dermatological practice. Part I: Main adverse effects
by: Thais Helena Proença de Freitas, et al.
Published: (2007)

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
by: Yiwen Bao, et al.
Published: (2024)

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
by: Kaibin Niu, et al.
Published: (2024)

Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System
by: Giuseppe Cicala, et al.
Published: (2024)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
by: Si Su, et al.
Published: (2023)

Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata
by: Fatemeh Rastaghi, et al.
Published: (2023)

Misuse of topical corticosteroids: A clinical study of adverse effects
by: Vivek Kumar Dey
Published: (2014)

Adverse Events Sustained by Children in The Intensive Care Unit: Guiding local quality improvement
by: Christopher James, et al.
Published: (2018)

Pembrolizumab-Associated Cardiotoxicity: A Retrospective Analysis of the FDA Adverse Events Reporting System
by: Stefan Milutinovic, et al.
Published: (2024)

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
by: Yunyan Pan, et al.
Published: (2024)

Neonatal factors predictive for respiratory and gastro-intestinal morbidity after esophageal atresia repair
by: Maissa Rayyan, et al.
Published: (2019)